Stay updated on KarXT for Schizophrenia: Long-term Clinical Trial
Sign up to get notified when there's something new on the KarXT for Schizophrenia: Long-term Clinical Trial page.

Latest updates to the KarXT for Schizophrenia: Long-term Clinical Trial page
- Check2 days agoChange DetectedAdded a new page revision tag: Revision: v3.5.4. The related topics section was updated to remove Schizophrenia and MedlinePlus Genetics, along with the older Revision: v3.5.3 label.SummaryDifference0.1%

- Check9 days agoChange DetectedNew topic tags were added to the study record: Schizophrenia and related topics including MedlinePlus Genetics. This enhances tagging and links to related consumer health information.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision: v3.5.3 was added and Revision: v3.5.2 was removed, representing a newer release of the document. It does not modify the study content or visible page information.SummaryDifference0.0%

- Check24 days agoChange DetectedSchizophrenia-related topics and MedlinePlus Genetics links were removed from the page’s resource sidebar. This does not change the study’s recorded details or results information.SummaryDifference0.1%

- Check31 days agoChange DetectedAdded related topic links for Schizophrenia and MedlinePlus Genetics, and updated the revision tag from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded sponsor attribution 'Karuna Therapeutics, Inc., a Bristol Myers Squibb company'. Removed the shorter sponsor name 'Karuna Therapeutics', the disease term 'Schizophrenia', and the related topic 'MedlinePlus Genetics' from the page.SummaryDifference0.2%

Stay in the know with updates to KarXT for Schizophrenia: Long-term Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Schizophrenia: Long-term Clinical Trial page.